(NASDAQ:NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced the ...

Modern Diagnostic IPO is being offered at a price band of ₹85 to ₹90 per share, with a lot size of 1,600 shares ...

India's diagnostics sector is accelerating capacity addition and geographic expansion, as large chains and regional players ...

Long COVID can linger long after the acute infection ends. People report fatigue, brain fog, dizziness, and poor sleep. Many ...

IIT Ropar researchers developed boronopeptides that detect Gram-positive bacteria about 40× more accurately and faster than current tests, enabling quicker diagnosis and better antibiotic use.

At Health First, this innovation is being brought to life through partners like NextGen Pathology, delivering precise diagnostic services.

Expanding U.S. market access with an experienced technology investor and AI-driven growth strategistVancouver, British Columbia--(Newsfile Corp. - December 30, 2025) - BioMark Diagnostics Inc. (CSE: ...

Union Health Minister J P Nadda held a crucial meeting to oversee the 'TB Mukt Bharat' campaign in Haryana, focusing on drug ...

PathoCare Holdings, Inc.—the parent company of medical diagnostics innovator PathoCare, LLC, a leader in Lab-on-a-Chip non-invasive Point-of-Care diagnostics—today announced that it has received a ...

The drug-resistant fungal species Candida auris is turning more deadly and is also spreading globally, according to a study ...

A nationwide survey by the Alzheimer’s Association in 2025 found close to 4 in 5 Americans 45 and older want to know if they have Alzheimer’s before symptoms appear. And 91% said they would take a ...